18/20. Selpercartinib-(RETEVMO)- (May 2020- to treat lung and thyroid cancers

Drug Name:
18/20. Selpercartinib-(RETEVMO)- (May 2020- to treat lung and thyroid cancers

List Of Brands:

Indication Type Description:

Drug Interaction

Indication

Adverse Reaction

Contra-Indications

Dosages/ Overdosage Etc

Patient Information

Pharmacology/ Pharmacokinetics

Pregnancy and lactation